@ShahidNShah
Latest CDC Update Clinicians Should Know When It Comes To COVID-19 Vaccine Reactions
At least 21 people in the U.S. have had serious allergic reactions to one of the two COVID-19 vaccines available on the market as the first few million doses of vaccine were administered last month, officials from the Centers for Disease Control and Prevention (CDC) said this week.
"I want to reassure you, this is still a rare outcome," Nancy Messonnier, M.D., head of the CDC's National Center for Immunization and Respiratory Diseases, said during a media briefing Wednesday.
However, the CDC said, individuals who have a reaction after their first dose of the vaccine should not get the second dose, officials said. What else should clinicians know as they field questions from patients about this new vaccine?
Continue reading at fiercehealthcare.com
Make faster decisions with community advice
- $10M Artificial Kidney Prize Now Live via HHS, American Society of Nephrology
- Germany Enables Free National Use of SNOMED CT
- HIMSSCast: What To Expect From 2021 Health Tech News
- Mercom: Telemedicine Investments Led 2020's $14.8B In Digital Health Fundraising
- New ONC tools To Help Developers Comply with New Interoperability Rules
Next Article
-
Mercom: Telemedicine Investments Led 2020's $14.8B In Digital Health Fundraising
While equity investments in telemedicine rose 139% to $4.3 billion, other areas like data analytics and mobile health apps also earned strong support from investors. Mercom Capital Group has released …
Posted Jan 8, 2021 Telemedicine Fundraisers